These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15145136)

  • 1. [In 2003, what are the indications of brachytherapy in coronary arteries?].
    Carrié D
    Pathol Biol (Paris); 2004 May; 52(4):223-7. PubMed ID: 15145136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients.
    Syeda B; Schukro C; Kirisits C; Lang I; Siostrzonek P; Gottsauner-Wolf M; Pokrajac B; Schmid R; Yahya N; Pötter R; Glogar D
    Radiother Oncol; 2006 Jan; 78(1):60-6. PubMed ID: 16309769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
    Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
    Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Past, present, and future of intracoronary brachytherapy].
    Angiolillo DJ; Sabaté M
    Ital Heart J Suppl; 2003 Oct; 4(10):794-806. PubMed ID: 14664291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive?
    Ruef J; Hofmann M; Störger H; Haase J
    Cardiovasc Revasc Med; 2007; 8(3):170-4. PubMed ID: 17765646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED Study.
    Park SW; Lee SW; Koo BK; Park DW; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Mori K; Lansky AJ; Mintz GS; Lee MM; Park SJ
    Int J Cardiol; 2008 Dec; 131(1):70-7. PubMed ID: 18190986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic total occlusion due to diffuse in-stent restenosis: is brachytherapy the solution?
    Nikolsky E; Gruberg L; Rosenblatt E; Grenadier E; Boulos M; Bernstein Z; Huber A; Gitman R; Bar-Deroma R; Markiewicz W; Beyar R
    Int J Cardiovasc Intervent; 2004; 6(1):33-8. PubMed ID: 15204171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular brachytherapy for patients with drug-eluting stent restenosis.
    Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcome of patients treated with beta-brachytherapy in routine clinical practice.
    Nikas DN; Kalef-Ezra J; Katsouras CS; Tsekeris P; Bozios G; Pappas C; Naka KK; Kotsia A; Papamichael N; Sideris DA; Michalis LK
    Int J Cardiol; 2007 Feb; 115(2):183-9. PubMed ID: 16890309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary brachytherapy. Treatment of in-stent restenosis with the Beta-Cath system. Initial experience in Latin America.
    Muñoz JS; Feres F; Abizaid AC; Mattos LA; Staico R; Centemero M; Tanajura LF; Pinto I; Sousa AG; Sousa JE
    Arq Bras Cardiol; 2004 Jul; 83(1):63-8; 57-62. PubMed ID: 15322668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis.
    Kuchulakanti P; Rha SW; Satler LF; Suddath WO; Pichard AD; Kent KM; Pakala R; Canos DA; Pinnow EE; Waksman R
    Am J Cardiol; 2004 Jun; 93(11):1394-7, A9. PubMed ID: 15165922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor outcome in patients treated with brachytherapy for diffuse in-stent restenosis. The role of additional stenting despite prolonged antiplatelet therapy.
    Zavalloni D; Rossi M; Belli G; Scatturin M; Morenghi E; Marsico F; Catalano G; Tosi G; Pagnotta P; Presbitero P
    J Invasive Cardiol; 2005 Nov; 17(11):598-602. PubMed ID: 16264205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis.
    Fasseas P; Orford JL; Lennon R; O'Neill J; Denktas AE; Panetta CJ; Berger PB; Holmes DR
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):152-7. PubMed ID: 15390249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta-radiation as adjuvant treatment of in-stent restenosis in coronary vessels].
    Maeng M; Tanderup K; Jessen KA; Krusell LR; Thuesen L
    Ugeskr Laeger; 2005 Aug; 167(33):3033-6. PubMed ID: 16109245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha particle vascular brachytherapy in the treatment of in-stent Restenosis.
    Mehdizadeh A; Fazelzadeh A; Karimi H
    Int J Cardiol; 2009 Aug; 136(2):220-1. PubMed ID: 18625530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed restenosis after gamma brachytherapy for in-stent restenosis.
    Hirose M; Kobayashi Y; Moses JW
    J Interv Cardiol; 2004 Aug; 17(4):215-8. PubMed ID: 15318893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.